1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 3: Orbit and spine MR imaging features at presentation for serum antibody-positive MOGAD
Orbital Involvement n =31 Spine Involvement n = 11
Unilateral 6/31 (19.4) Long segment 4/11 (36.4)
Bilateral 25/31 (80.6) Short segment 6/11 (54.5)
Segments involved Cauda equina enhancement 1/11 (9.1)
 Orbital 24/31 (77.4) Focality 
 Intracanalicular 20/31 (64.5)  Unifocal 3/11 (27.3)
 Prechiasmatic 17/31 (54.8)  Multifocal 8/11 (72.7)
 Optic chiasm 5/31 (16.1) Location 
 Optic tract 4/31 (12.9)  Cervical 8/11 (72.7)
Optic nerve enhancement^a 25/29 (86.2)  Thoracic 6/11 (54.5)
Perineural enhancement^b 17/25 (68)  Conus 5/11 (45.4)
Optic nerve low diffusivity^c 10/15 (66.7)  Cauda equina 1/11 (9)
Pattern 
 Central 6/11 (54.5)
 Peripheral 4/11 (36.4)
 Entire cross-section 3/11 (27.3)
 Central gray only 4/11 (36.4)
Enhancement 
 None 7/11 (63.6)
 Intramedullary 3/11 (27.3)
 Leptomeningeal 1/11 (9)
Cord expansion 5/11 (45.4)
^aUnknown in 2 patients due to absence of contrast.
^bUnknown in 6 patients due to absence of contrast and/or fat saturation.
^cUnknown in 16 patients due to missing DWI sequence.